SolitAir: Redefining Cargo Aviation in the Global South – A Startup’s Remarkable Rise
In the fast-moving world of international cargo logistics, some companies take decades to establish a credible footprint. SolitAir has done it in just a year. Establishing its operations in October 2024, this UAE-based exclusive cargo airline has rapidly emerged as a transformative force in air freight, with accomplishments that defy its startup status. A Startup […]
8 Ways BSL-2 Compliant Processes Can Attract More Clients
When you run a business that deals with biological materials, safety is never optional. For organisations that are concerned with pharmaceuticals, healthcare, food testing, or research services, adopting processes that meet Biosafety Level 2 laboratory standards may be a regulatory requirement. Beyond compliance, however, adhering to processes that meet BSL-2 conditions can also be a […]
IonQ Expands Global Reach with Fronte Enterprise on AWS and Quantum Cloud
IonQ, a leader in the quantum computing and networking industries, recently announced that IonQ Forte Enterprise, IonQ’s recently commissioned quantum computer is now officially available to customers globally through Amazon Braket, a managed quantum computing service from Amazon Web Services (AWS), as well as the IonQ Quantum Cloud. IonQ Forte Enterprise joins IonQ Aria and IonQ Forte […]
Crypto for Entrepreneurs: Building a Business in the Blockchain Era
Blockchain technology has given a new meaning to entrepreneurship and changed the traditional business model of running a business in innovative ways. Don’t mistake blockchain for another trendy term; it’s a way to increase transparency and scalability and to become a global influence. For those entrepreneurs who look ahead, blockchain and cryptocurrency represent possibilities that […]
Patterson Belknap Announces IP Litigator Kathryn Bi as Its Partner
Patterson Belknap announced that Kathryn Bi has joined the firm as a Partner in its Litigation department and as a member of the Patent Litigation practice. Ms. Bi helps clients resolve their toughest intellectual property and commercial cases, focusing her practice on complex technology disputes. She has successfully represented tech companies in numerous high-stakes patent cases. Ms. […]
PureTech Announces the Appointment of Michele Holcomb, PhD, to the Board of Directors
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, recently announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb’s appointment will take effect as of September 23, 2024. She brings more […]
Botanical Solution Inc. Announces Closing of Series A Funding
Botanical Solution Inc. (BSI) announced it has closed another $7.6 million financing, as part of Series A, that will fund the commencement of in-house production of QS-21, pharmaceutical grade vaccine adjuvant. Using cost-effective and scalable proprietary methods, BSI will expand QS-21 use in broader vaccine applications. Mr. Salinas made the announcement at Harvard University’s Global […]
Swisslog Healthcare appoints Brian Roberts as SVP of Medication Management, North America
Swisslog Healthcare, a global industry leader in pharmacy and transport automation solutions, announced the appointment of Brian Roberts as the Senior Vice President of Sales and Services in North America for the Medication Management business unit. With a wealth of experience in pharmacy automation, business-to-business healthcare applications, and executive leadership, Roberts brings a proven track record of success to […]
Prothena appoints Daniel G. Welch as Director and Chair Designate
Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced yesterday the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate following a comprehensive search process in connection with the board’s regular succession planning. Upon election […]
Gilead Sciences announces the acquisition of CymaBay Therapeutics
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced yesterday a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver […]
